СОВИД-19 ИНФЕКЦИЯСИНИНГ ҚАЛҚОНСИМОН БЕЗ ТЎҚИМАСИГА ТАЪСИРИНИ ЎРГАНИШ
Keywords:
Коронавирус инфекция, COVID-19, қалқонсимон без, тиреоидит.Abstract
Мақолада анамнезида қалқонсимон без касаллиги бор ва қалқонсимон без касаллиги йўқ беморларда COVID-19 инфекциясининг қалқонсимон без тўқимасига УТТ ва гистология натижалари орқали бахоланганлиги ўрганилган. Олинган натижаларга кўра COVID-19 инфекцияси билан касалланган анамнезида қалқонсимон без касаллиги бўлган 200 та беморда қалқонсимон без хажми катталашганлиги , қалқонсимон без касаллиги бўлмаган беморларга нисбатан III-даражада катталашган буқоқлар 34%га, IV-даражада катталашган буқоқлар эса 2%га кўпайганлиги аниқланди. Қалқонсимон без тўқимасида аниқланган касалликлар тахлил қилинганда 1-гурухдаги анамнезида қалқонсимон без касалликлари бўлган беморларда COVID-19 инфекциясидан кейин кўп тугунли буқоқ шакллари аниқланди ва гистология текширув натижаларида қалқонсимон без саратони касаллиги тасдиқланди.
References
Lisco G, De Tullio A, Jirillo E, et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J Endocrinol Invest 2021; 44: 1801–1814.
Scappaticcio L, Pitoia F, Esposito K, et al. Impact of COVID-19 on the thyroid gland: an update.Rev Endocr Metab Disord2020: 22: 1–13.
Chen W, Tian Y, Li Z, et al. Potential Interaction Between SARS-CoV-2 and Thyroid: A Review. Endocrinology 2021; 162: bqab004.
Wu Z and McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242.
Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell 2020; 181: 1016–1035.e19.
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature2003; 426: 450–454.
Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.BMJ2020; 368: m1091.
Marazuela M, Giustina A and PuigDomingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord2020; 21: 495–507.
Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med2020; 383: 120–128.
Dufort EM, Koumans EH, Chow EJ, et al. Multisystem Inflammatory Syndrome in Children in New York State.N Engl J Med2020; 383: 347–358.
Coperchini F, Chiovato L, Croce L, et al. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/ chemokine-receptor system. Cytokine Growth Factor Rev2020; 53: 25–32.
Java A, Apicelli AJ, Liszewski MK, et al. The complement system in COVID-19: friend and foe?JCI Insight2020; 5: e140711.
Guo Y, Korteweg C, McNutt MA, et al. Pathogenetic mechanisms of severe acute respiratory syndrome. Virus Res 2008; 133: 4–12.
Lazartigues E, Qadir MMF and MauvaisJarvis F. Endocrine Significance of SARSCoV-2’s Reliance on ACE2.Endocrinology 2020; 161: bqaa108.
Li MY, Li L, Zhang Y, et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.Infect Dis Poverty2020; 9: 45.
